Access

Letter

Nature 451, 587-590 (31 January 2008) | doi:10.1038/nature06515; Received 12 July 2007; Accepted 27 November 2007

Open Innovation Challenges

naturejobs

Negative regulation of the deacetylase SIRT1 by DBC1

Wenhui Zhao1,3, Jan-Philipp Kruse1,3, Yi Tang1,3, Sung Yun Jung2, Jun Qin2 & Wei Gu1

  1. Institute for Cancer Genetics, and Department of Pathology College of Physicians and Surgeons, Columbia University, 1130 St Nicholas Avenue, New York, New York 10032, USA
  2. Departments of Biochemistry and Cell Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
  3. These authors contributed equally to this work.

Correspondence to: Wei Gu1 Correspondence and requests for materials should be addressed to W.G. (Email: wg8@columbia.edu).

Top

SIRT1 is an NAD-dependent deacetylase critically involved in stress responses, cellular metabolism and, possibly, ageing1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15. The tumour suppressor p53 represents the first non-histone substrate functionally regulated by acetylation and deacetylation16, 17; we and others previously found that SIRT1 promotes cell survival by deacetylating p53 (refs 4–6). These results were further supported by the fact that p53 hyperacetylation and increased radiation-induced apoptosis were observed in Sirt1-deficient mice10. Nevertheless, SIRT1-mediated deacetylase function is also implicated in p53-independent pathways under different cellular contexts, and its effects on transcriptional factors such as members of the FOXO family and PGC-1alpha directly modulate metabolic responses1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15. These studies validate the importance of the deacetylase activity of SIRT1, but how SIRT1 activity is regulated in vivo is not well understood. Here we show that DBC1 (deleted in breast cancer 1) acts as a native inhibitor of SIRT1 in human cells. DBC1-mediated repression of SIRT1 leads to increasing levels of p53 acetylation and upregulation of p53-mediated function. In contrast, depletion of endogenous DBC1 by RNA interference (RNAi) stimulates SIRT1-mediated deacetylation of p53 and inhibits p53-dependent apoptosis. Notably, these effects can be reversed in cells by concomitant knockdown of endogenous SIRT1. Our study demonstrates that DBC1 promotes p53-mediated apoptosis through specific inhibition of SIRT1.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Research Highlights

Nature Chemical Biology News and Views (01 Feb 2006)

Getting a grip on O-acetyl-ADP-ribose

Nature Structural & Molecular Biology News and Views (01 Jul 2005)

See all 3 matches for News And Views